Specific Immunotherapy with Standardized Latex Extract versus Placebo in Latex-Allergic Patients
Authors:
- Marta AndaMAMarta Anda
- Floriano BonifaziFBFloriano Bonifazi
- Maria Beatrice BilòMBMaria Beatrice Bilò
- Francisque LeynadierFLFrancisque Leynadier
- Thomas FuchsTFThomas Fuchs
- Johannes RingJRJohannes Ring
- Sylvie GalvainSGSylvie Galvain
- Claude AndréCAClaude André
- 1 November 2006
- journal article
- research article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 141 (4) , 369-376
Abstract
Background: Allergy to natural rubber latex proteins continues to be an important medical problem among health care professionals, but also in multioperated children. Clinical manifestations range from urticaria to angioedema, rhinoconjunctivitis, bronchial asthma and anaphylactic shock. Methods: The aim of this study was to investigate the efficacy and safety of a 12-month latex-specific immunotherapy in sensitized patients, most often health care workers. Twenty-three patients with latex rhinoconjunctivitis (20 of whom also had asthma) were included in this randomized, double-blind, placebo-controlled trial (11 in the active group, 12 in the placebo group). Treatment efficacy was assessed by means of symptom and medication scores. Conjunctival provocation tests and quantitative skin prick tests were also performed. Results: The clinical index (derived by combining changes from baseline of six efficacy variables during the treatment period) did not differ significantly between treatment groups. Change from baseline of rhinitis, conjunctivitis, skin symptoms, asthma symptoms, medication score and cutaneous reactivity were not significantly different between the two groups. A nonsignificant difference in conjunctival reactivity was observed in favor of the active group (p = 0.09). Systemic reactions were much higher in the specific immunotherapy than in the placebo group. Conclusions: The present study failed to show a significant improvement of symptoms and medication scores, probably because of the low level of symptoms at baseline and the low maintenance dose of therapy, even if allergen-specific conjunctival reactivity decreased in the active group. Moreover, the incidence of systemic reactions was very high in the active group.Keywords
This publication has 20 references indexed in Scilit:
- Clinical and occupational outcomes in health care workers with natural rubber latex allergyAnnals of Allergy, Asthma & Immunology, 2003
- Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workersJournal of Allergy and Clinical Immunology, 2000
- Specific immunotherapy for occupational latex allergyAllergy, 1999
- Latex Antigens: Identification and Use in Clinical and Experimental Studies, Including Crossreactivity with Food and Pollen AllergensAnnals of Allergy, Asthma & Immunology, 1998
- Latex allergyClinical & Experimental Allergy, 1995
- Banana allergy in patients with immediate-type hypersensitivity to natural rubber latex: Characterization of cross-reacting antibodies and allergensJournal of Allergy and Clinical Immunology, 1994
- Allergy to latexAllergy, 1992
- Latex antigensJournal of Allergy and Clinical Immunology, 1992
- Conjunctival Allergen ChallengeArchives of Ophthalmology (1950), 1990
- Hypersensitivity to natural latexJournal of Allergy and Clinical Immunology, 1989